Poster Presented at Association for Molecular Pathology Annual Meeting Highlights Potential to Improve Diagnostic Success Across Preanalytical Solutions simplSEQ, Inc.,... View Article
The U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for simplSEQ’s patent application No. 17/331,532 for... View Article
This poster was presented on September 28, 2021 at the Sequencing to Function: Analysis and Application for the Future conference.... View Article
Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary, will... View Article
Murrieta Genomics, the launch pad for genomic sequencing startups, has announced that simplSEQ, an incubator company, has completed its seed round... View Article
The management team at SimplSeq is pleased to announce that it has received a $500,000 investment in the company, concluding... View Article
SimplSeq, the company dedicated to simplifying the genomic sequencing workflow process, has announced that a second provisional patent application has... View Article
SimplSeq, the company dedicated to simplifying the genomic sequencing workflow process, has retained digital marketing agency Mind & Mill of... View Article
John C. Spinosa, M.D., Ph.D., has joined the executive management team as our Chief Medical Officer. Below is the text... View Article
On Friday, January 29th 2021, an article about SimplSEQ was published by GenomeWeb, an online news organization serving the global... View Article